Apollo Capital Wins Proxy Contest at MediPharm Labs

Core Viewpoint - Apollo Capital claims victory in the proxy contest for MediPharm Labs, asserting that all proxies solicited by MediPharm are illegal and invalid under securities law, leading to the appointment of Apollo's nominees to the board [1][7][11] Group 1: Legal Violations - MediPharm's solicitation of proxies for the Annual Meeting is deemed illegal due to non-compliance with notice-and-access laws, specifically including prohibited materials in proxy mailings [2][3] - The legal failures acknowledged by MediPharm are not curable, indicating a disregard for shareholder rights and legal compliance [3][6] - Meeting Chair Chris Halyk is urged to declare the green proxy votes as illegal, reinforcing the validity of Apollo's GOLD proxies [4][10] Group 2: Shareholder Rights and Governance - Apollo Capital emphasizes the need for new leadership at MediPharm, citing massive value destruction and poor governance under the current board [6][8] - The current board's actions are characterized as unlawful and self-serving, aimed at entrenching their positions at the expense of shareholders [8][10] - Apollo Capital's GOLD proxies are the only valid ones, as they adhered to the rules governing proxy solicitation, contrasting with MediPharm's approach [7][11] Group 3: Future Outlook - Apollo Capital expresses intentions to work with shareholders to restore value and integrity to MediPharm, aiming to increase the share price above $1 per share [11]